Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a preclinical in vivo proof-of-concept study of a novel nanoparticle platform in mice; it demonstrates mechanistic feasibility but lacks clinical translation, efficacy comparators, or human data needed to guide clinical practice.